Faculty Opinions recommendation of NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
Shin‐ichiro Imai
Abstract
Open-access reader
Shin‐ichiro Imai
Abstract
Open-access reader
NAD þ is a vital redox cofactor and a substrate required for activity of various enzyme families, including sirtuins and poly(ADP-ribose) polymerases.Supplementation with NAD þ precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neurodegenerative disorders and age-related physiological decline in mammals.Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD þ synthesis.Using genetic gain-and loss-of-function models, we further demonstrate that the role of NRK1 in driving NAD þ synthesis from other NAD þ precursors, such as nicotinamide or nicotinic acid, is dispensable.Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD þ .Our results indicate that mammalian cells require conversion of extracellular NMN to NR for cellular uptake and NAD þ synthesis, explaining the overlapping metabolic effects observed with the two compounds.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
NAD þ is a vital redox cofactor and a substrate required for activity of various enzyme families, including sirtuins and poly(ADP-ribose) polymerases.Supplementation with NAD þ precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neurodegenerative disorders and age-related physiological decline in mammals.Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD þ synthesis.Using genetic gain-and loss-of-function models, we further demonstrate that the role of NRK1 in driving NAD þ synthesis from other NAD þ precursors, such as nicotinamide or nicotinic acid, is dispensable.Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD þ .Our results indicate that mammalian cells require conversion of extracellular NMN to NR for cellular uptake and NAD þ synthesis, explaining the overlapping metabolic effects observed with the two compounds.
Key concepts: Nicotinamide mononucleotide, NAD+ kinase, Nicotinamide, Nicotinamide phosphoribosyltransferase, Nicotinamide adenine dinucleotide, Cofactor, Biochemistry, Niacinamide